About Apotheca Biosciences

Apotheca Biosciences is developing cutting-edge medical products, nutraceuticals, formulation and delivery technologies for the healthcare and consumer care industry. Our pipeline of products includes, transdermal, sublingual, and nasal delivery technologies for precise and controlled dosing of cannabinoids. We believe that we can deliver meaningful benefits using our technologies to the world’s aging population.

Apotheca Biosciences is an pioneering biotech company with an emphasis in research and development in addition to the creation of high-grade nutraceuticals and cosmetics. The health of our customers takes precedence and our solid business strategy ensures our focus on customer well being. Our goal is to lay the groundwork and continue research of cannabinoid receptiveness in patients and create nutraceuticals that reflects our research.

The last two decades of research have brought a tremendous improvement in knowledge of the endocannabinoid system (eCB system) components and functions under physiological and pathological conditions. The eCB is a neuromodulatory system consists of two subtypes of cannabinoid receptors, CB1 and CB2.

The Human Endocannabinoid System

The Human Endocannabinoid System

CBD, CBN and THC fit like a lock and key into existing human receptors. These receptors are part of the enocannabinoid system which impact physiological processes affecting pain modulation, memory, appetite, anti-inflammatory effects and other immune system reponses. The endocannabinoid system comprises two types of receptors, CB1 and CB2, which serve distinct functions in human health and well-being.

CBD does not directly “fit” CB1 or CB2 receptors but has powerful indirect effects still being studied.

CB1 receptors are primarily found in the brain and central nervous system and to a lesser extent in other tissues.

CB2 receptors are mostly in the perepheral organs especially cells associated with the immune system.

CB1 Refining in Lab

CB1 receptors are the most abundant in the central neural system, expressed in both neurons and glial cells, where they regulate important brain functions including cognition and memory, emotion, motor control, feeding, and pain perception.

CB1 receptors are mostly located at the terminals of neurons of the central and peripheral nervous system where they act as modulators of excitatory and inhibitory neurotransmission.

CB1 receptors are also found in peripheral tissues, playing an important role in energy balance and metabolism. CB2 receptors are localized in cells of the immune system and modulate the immune cell migration and the release of cytokines; within the nervous system CB2 receptors are mainly located in microglia. Together these two receptors modulate the proper functioning of eCB system is extremely critical for day-to-day functions of our bodies, Newest research have shown that eCB system is as important as human immune system and have a major role in the healthy aging of human beings.

Phytocannabinoids are molecules from Cannabis plant which modulates cannabinoids. Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) are two major phytocannabinoid compound derived from the hemp plant that have significant potential as a therapeutic targets across an array of peripheral and neuropsychiatric disease states.

Board Of Directors

Sam Talari

Board Of Directors

Management Team

Welcome to our experienced and seasoned team of leaders that push the boundaries of nature and science.

Dr. P.C. Sundareswaran

Chief Executive Officer

John Verghese

M.S., Chief Technology Officer

Deirdre Fernandes

Chief Operations Officer

Scientific Advisory Board

Dr. Vipul Shah

Pain Management

Dr. Michael Mendez

Biopharmaceutical Industry leader

Strategic Partnerships

Apotheca Biosciences has built several strategic relations with physician groups and other healthcare entities to enhance the vision and mission of the company. The company also has joint development research with HempTech Inc, a cannabis grow company and CB Scientific, an innovative medical device company.

Strategic Partnership
Molecular Model

Manufacturing Capabilities

R & D Capabilities:
Apotheca Biosciences’ R & D capabilities includes state-of-the art extraction equipments and a dosage formulation lab to develop various forms of pharmaceutical-grade formulation. This includes steam and CO2 extractors, nano emulsion sprayers, high-shear mixers, and analytical equipment to precisely measure the components of cannabis.

Manufacturing Capabilities:
Apotheca Biosciences’ is installing a world-class production facility to manufacture various hemp-derived products. The 3000 square feet production facility conforms to the ISO 14644-1/14698 standards and houses ISO 2 & 3 class clean rooms. This facility allows us to produce the highest quality products for our customers .